Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?

Affiliations

• ¹ Drug Development Department (DITEP), Paris Saclay University, Gustave Roussy, Villejuif, France. Electronic address: paul.matte@hotmail.fr.
• ² Drug Development Department (DITEP), Paris Saclay University, Gustave Roussy, Villejuif, France.
• ³ Child and Adolescent Psychiatry Department, Robert Debré Hospital, APHP, 48 boulevard Sérurier, 75019 Paris, France.
• ⁴ Psycho-Oncology Unit, Paris Saclay University, Gustave Roussy, Villejuif, France.
• ⁵ Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), F-75004 Paris, France; Service de Psychiatrie de l'adulte, AP-HP, Hôpital Hôtel-Dieu, F-75004 Paris, France.